What we offer
The COVID-19 Treatment Initiative (CTI) has begun providing services throughout North America. We are focused on expanding all three of our monoclonal antibody treatment options to as many areas as possible.
mAbs at Home
Many patients can receive their treatment safely and efficiently at home.
For mAbs at home, a doctor reviews a patient’s qualification form and recommends a course of treatment. A nurse will come to the patient’s home to administer mAbs.
See if you qualify now.
Local Treatment Centers
For those who can or prefer to go in for treatment, CTI has set up a number of sites.
These centers are staffed by medical professionals and are set up to comfortably provide patients with monoclonal antibody infusions.
Find a center near you.
Long-term care facilities can provide mAbs to all residents of an LTC facility when there is a positive case of COVID-19 reported on-site. CTI will arrange a team of doctors and nurses to provide treatment in-house. The team will coordinate ahead of time so that treatment is efficient and does not affect existing LTC staff duties or facility operations.
Learn more about our LTC teams
You can be proactive about COVID-19.
Connect with your local CTI service now.